TCDB is operated by the Saier Lab Bioinformatics Group
« See all members of the family


2.A.22.1.1
Serotonin (5-hydroxytryptamine; 5 HT):Na+:Cl- symporter, SERT-A  It also transports amphetamines; blocked by cocaine and tricyclic antidepressants such as Prozac; interacts directly with the secretory carrier-associated membrane protein-2 (SCAMP2; O15127) to regulate the subcellular distribution (Muller et al., 2006). The 3 D structure is known ()PDB 5I6X), and it uses an alternating sites mechanism with all 3 substrates bound (Zhang and Rudnick, 2006).  Molecular determinants for antidepressants in the human serotonin and norepinephrine A transporters have been identified (Andersen et al., 2011). A conserved asparagine residue in transmembrane segment 1 (TMS1) of the serotonin transporter dictates chloride-coupled neurotransmitter transport (Henry et al., 2011). The formation and breakage of ionic interactions with amino acids in transmembrane helices 6 and 8 and intracellular loop 1 may be of importance for substrate translocation (Gabrielsen et al., 2012). Methylation of the SLC6A4 gene promoter controls depression in men by an epigenetic mechanism (Devlin et al., 2010).  The 5HT Km is 0.4 micromolar (Banovic et al. 2010).  Regulated allosterically by ATM7 which stabilizes the outward-facing conformation of SERT (Kortagere et al. 2013).  Functional and regulatory mechanisms involving the N- and C-terminal hydrophilic domains have been considered (Fenollar-Ferrer et al. 2014).  The range of substrates bound and transported has been predicted (Kaufmann et al. 2009).  TMS3 may function in substrate and antagonist recognition (Walline et al. 2008).  The 3-d x-ray structures with antidepressants bound have been solved, leading to mechanistic predictions; antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between TMSs 1, 3, 6, 8 and 10, directly blocking serotonin binding (Coleman et al. 2016).  Na+ and cocaine stabilize outward-open conformations of SERT and decrease phosphorylation while agents that stabilize inward-open conformations (e.g., 5-HT, ibogaine) increase phosphorylation. The opposing effects of the inhibitors, cocaine and ibogaine, were each reversed by an excess of the other inhibitor. Inhibition of phosphorylation by Na+ and stimulation by ibogaine occurred at concentrations that induced outward opening and inward opening, respectively (Zhang et al. 2016).  SERT is regulated by multiple molecular mechanisms including its physical interaction with intracellular proteins including the ASCT2 (alanine-serine-cysteine-threonine 2; TC# 2.A.23.3.2), co-expressed with SERT in serotonergic neurons and involved in the transport of small neutral amino acids across the plasma membrane (Seyer et al. 2016).  SERT transports substituted amphetamine, 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) (Sealover et al. 2016).  A naturally occurring mutation, I425V, associated with obsessive-compulsive disorder and other neuropsychiatric disorders, activates hSERT and eliminates stimulation via the cyclicGMP-dependent pathway (Zhang et al. 2007).  The substituted amphetamine, 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy), is a widely used drug of abuse that induces non-exocytotic release of serotonin, dopamine, and norepinephrine through their cognate transporters as well as blocking the reuptake of neurotransmitter by the same transporters. In SERT, Glu394 plays a role in MDMA recognition (Sealover et al. 2016). Intestinal dysbiosis may upregulate SERT expression and contribute to the development of chronic constipation (Cao et al. 2017). Cryo-EM structures of SERT-ibogaine complexes captured in outward-open, occluded and inward-open conformations have been solved (Coleman et al. 2019). Ibogaine binds to the central binding site, and closure of the extracellular gate largely involves movements of TMSs 1b and 6a. Opening of the intracellular gate involves a hinge-like movement of TMS 1a and the partial unwinding of TMS 5, which together create a permeation pathway that enables substrate and ion diffusion to the cytoplasm, thus defining the structural rearrangements that occur from the outward-open to inward-open conformations. SERT and cholecytokinin (CCK) seem to be involved in the pathogenesis of Irrritable Bowl Syndrome (IBS-D) by regulating the brain-gut axis and affecting visceral sensitivity (Qin et al. 2020). Altered SERT function leads to several neurological diseases including depression, anxiety, mood disorders, and attention deficit hyperactivity disorders (ADHD) (Szöllősi and Stockner 2021). The structure and dynamics of the two sodium binding sites indicate that sodium binding is accompanied by an induced-fit mechanism that leads to new conformations (Szöllősi and Stockner 2021). Occlusion of the  serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain (Gradisch et al. 2022). A structural rearrangement of the SERT intracellular gate is induced by Thr276 phosphorylation (Chan et al. 2022). Na+/Cl--dependent neurotransmitter transporters form oligomers. A leucine heptad repeat in TMS2 and a glycophorin-like motif in TMS6 may stabilize the oligomer (Just et al. 2004). Oligomerization of hSERT involves at least two discontinuous interfaces to form an array-like structure containing multimers of dimers (Just et al. 2004). Degenerative mitral valve (MV) regurgitation (MR) is a highly prevalent heart disease that requires surgery in severe cases. A decrease in the activity of the serotonin transporter (SERT) accelerates MV remodeling and progression to MR; decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation (Castillero et al. 2023). Cocaine-regulated trafficking of dopamine transporters in cultured neurons has been revealed using a pH sensitive reporter (Saenz et al. 2023). Two SERT ligands, fluoxetine and escitalopram, enter neurons within minutes, while simultaneously accumulating in many membranes (Nichols et al. 2023). Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region (Hu et al. 2012). Dehydroevodiamine has a dihedral angle of 3.71 degrees compared to 82.34 degrees for evodiamine. Dehydroevodiamine can more easily pass through a phospholipid bilayer than evodiamine because it has a more planar stereo-structure (Luo et al. 2023).  SLC6A4 gene variants moderate associations between childhood food insecurity and adolescent mental health (Pilkay et al. 2024). 

Accession Number:P31645
Protein Name:NTSE aka SLC6A4 aka HTT aka SERT
Length:630
Molecular Weight:70325.00
Species:Homo sapiens (Human) [9606]
Number of TMSs:11
Location1 / Topology2 / Orientation3: Membrane1 / Multi-pass membrane protein2
Substrate chloride, sodium(1+), serotonin, amphetamine

Cross database links:

RefSeq: NP_001036.1   
Entrez Gene ID: 6532   
Pfam: PF03491    PF00209   
OMIM: 103780  phenotype
164230  phenotype
182138  gene
KEGG: hsa:6532    hsa:6532   

Gene Ontology

GO:0005829 C:cytosol
GO:0005887 C:integral to plasma membrane
GO:0008022 F:protein C-terminus binding
GO:0015222 F:serotonin transmembrane transporter activity
GO:0005335 F:serotonin:sodium symporter activity
GO:0009636 P:response to toxin
GO:0051610 P:serotonin uptake
GO:0021794 P:thalamus development
GO:0012505 C:endomembrane system
GO:0010008 C:endosome membrane
GO:0045121 C:membrane raft
GO:0019717 C:synaptosome
GO:0019811 F:cocaine binding
GO:0048854 P:brain morphogenesis
GO:0071321 P:cellular response to cGMP
GO:0071300 P:cellular response to retinoic acid
GO:0007623 P:circadian rhythm
GO:0007613 P:memory
GO:0021941 P:negative regulation of cerebellar granule cell precursor proliferation
GO:0045665 P:negative regulation of neuron differentiation
GO:0046621 P:negative regulation of organ growth
GO:0032227 P:negative regulation of synaptic transmission, dopaminergic
GO:0045787 P:positive regulation of cell cycle
GO:0010628 P:positive regulation of gene expression
GO:0051260 P:protein homooligomerization
GO:0051259 P:protein oligomerization
GO:0042493 P:response to drug
GO:0032355 P:response to estradiol stimulus
GO:0001666 P:response to hypoxia
GO:0035176 P:social behavior
GO:0042713 P:sperm ejaculation
GO:0042310 P:vasoconstriction

References (26)

[1] “Isolation of a cDNA encoding the human brain serotonin transporter.”  Lesch K.P.et.al.   8452685
[2] “Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.”  Ramamoorthy S.et.al.   7681602
[3] “Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.”  Lesch K.P.et.al.   7684072
[4] “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).”  The MGC Project Teamet.al.   15489334
[5] “Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.”  Carneiro A.M.D.et.al.   16803896
[6] “Characterization of single-nucleotide polymorphisms in coding regions of human genes.”  Cargill M.et.al.   10391209
[7] “Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.”  Ozaki N.et.al.   14593431
[8] “A human serotonin transporter mutation causes constitutive activation of transport activity.”  Kilic F.et.al.   12869649
[9] “Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.”  Caspi A.et.al.   12869766
[10] “Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence.”  Feinn R.et.al.   15635638
[11] “Isolation of a cDNA encoding the human brain serotonin transporter.”  Lesch K.P.et.al.   8452685
[12] “Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.”  Ramamoorthy S.et.al.   7681602
[13] “Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.”  Lesch K.P.et.al.   7684072
[14] “Molecular characterization and intracellular regulation of the human serotonin transporter in Caco-2 cells.”  Iceta R.et.al.   16601320
[15] “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).”  The MGC Project Teamet.al.   15489334
[16] “Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.”  Carneiro A.M.D.et.al.   16803896
[17] “Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2.”  Mueller H.K.et.al.   16870614
[18] “Plasma serotonin levels and the platelet serotonin transporter.”  Brenner B.et.al.   17506858
[19] “Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter.”  Ahmed B.A.et.al.   18227069
[20] “The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network.”  Ahmed B.A.et.al.   19270731
[21] “Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function.”  Annamalai B.et.al.   21992875
[22] “Characterization of single-nucleotide polymorphisms in coding regions of human genes.”  Cargill M.et.al.   10391209
[23] “Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.”  Ozaki N.et.al.   14593431
[24] “A human serotonin transporter mutation causes constitutive activation of transport activity.”  Kilic F.et.al.   12869649
[25] “Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.”  Caspi A.et.al.   12869766
[26] “Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence.”  Feinn R.et.al.   15635638
Structure:
5i6x   5i6z   5I71   5I73   5I74   5I75   6AWN   6AWO   6AWP   6AWQ   [...more]

External Searches:

Analyze:

Predict TMSs (Predict number of transmembrane segments)
Window Size: Angle:  
FASTA formatted sequence
1:	METTPLNSQK QLSACEDGED CQENGVLQKV VPTPGDKVES GQISNGYSAV PSPGAGDDTR 
61:	HSIPATTTTL VAELHQGERE TWGKKVDFLL SVIGYAVDLG NVWRFPYICY QNGGGAFLLP 
121:	YTIMAIFGGI PLFYMELALG QYHRNGCISI WRKICPIFKG IGYAICIIAF YIASYYNTIM 
181:	AWALYYLISS FTDQLPWTSC KNSWNTGNCT NYFSEDNITW TLHSTSPAEE FYTRHVLQIH 
241:	RSKGLQDLGG ISWQLALCIM LIFTVIYFSI WKGVKTSGKV VWVTATFPYI ILSVLLVRGA 
301:	TLPGAWRGVL FYLKPNWQKL LETGVWIDAA AQIFFSLGPG FGVLLAFASY NKFNNNCYQD 
361:	ALVTSVVNCM TSFVSGFVIF TVLGYMAEMR NEDVSEVAKD AGPSLLFITY AEAIANMPAS 
421:	TFFAIIFFLM LITLGLDSTF AGLEGVITAV LDEFPHVWAK RRERFVLAVV ITCFFGSLVT 
481:	LTFGGAYVVK LLEEYATGPA VLTVALIEAV AVSWFYGITQ FCRDVKEMLG FSPGWFWRIC 
541:	WVAISPLFLL FIICSFLMSP PQLRLFQYNY PYWSIILGYC IGTSSFICIP TYIAYRLIIT 
601:	PGTFKERIIK SITPETPTEI PCGDIRLNAV